Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terazosin in Parkinson's Disease
NCT07464028Phase 2Suspended
- Sponsor
- Ergun Y. Uc
- Start
- Jul 2028
- Primary completion
- Jul 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of terazosin in Parkinson's disease (PD), sponsored by Ergun Y. Uc. Planned start Jul 2028; status: suspended.
02
Drugs
terazosin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07464028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07464028.